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Abstract 
Psychological stress plays a vital role in skin disease. The worsening and reoccurrence of signs 
and symptoms of a wide array of skin diseases have been linked by various studies to stress. 
Together, stress and skin disease synergistically inhibit occupational, social, and emotional 
functioning resulting in diminished quality of life (Dixon, Witcraft, & Perry, 2019). 
Heightened levels of stress may contribute to an assortment of immediate and future adverse 
outcomes. These outcomes include triggering a skin outbreak, impairing function, behavioral 
avoidance, intense negative emotions such as shame and embarrassment, and emotional 
distress such as depression and anxiety (Dixon et al., 2019). The purpose of this paper is to 
discuss the relationship of stress, anxiety, and depression to the specific chronic skin diseases 
of acne vulgaris, psoriasis, vitiligo, rosacea, and atopic dermatitis. It will also discuss how a 
psychotherapeutic intervention called mindfulness-based stress reduction (MBSR) may 
decrease anxiety and depression in individuals affected by chronic skin diseases. This paper 
will also highlight the impact of MBSR on treatment adherence to dermatological prescription 
medications.  A pilot program conducted in a dermatology clinic evaluates the effectiveness of 
an online mindfulness-based stress reduction intervention to decrease patient anxiety and 
depression.  Results indicate clinical significance in that participants noted reduced anxiety and 
depression symptoms and scores, enjoyed MBSR and would continue MBSR.  The potential 
benefits of this pilot program may include decreased patient anxiety and depression, increased 
patient satisfaction, increased treatment adherence, improved patient satisfaction of 
intervention, and improved patient outcomes.   
 Keywords: skin disease, anxiety, depression, mindfulness, stress, dermatology, MBSR 
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Mindfulness-Based Stress Reduction: A Psychotherapeutic Intervention in Patients with 
Dermatological Diseases 
 The psychological effects of skin disease are often more devastating for the patient than 
can be objectively evaluated by a healthcare provider.  Irrespective of its outward 
manifestations and severity, conditions of the skin can cause severe negative psychological 
impacts.  Stress is a significant role player in all types of skin disease. Together, stress and skin 
disease hinder physical, occupational, social, emotional, and mental functioning, resulting in 
diminished quality of life (Dixon, Witcraft, & Perry, 2019; Salman et al., 2016).  
Problem 
 One of the most common human diseases causing global burden is skin disease.  The 
World Health Organization's International Classification of Disease 10 classifies more than 
1,000 skin or skin-related illnesses (World Health Organization, 2019).  Psychological stress 
plays an essential role in skin disease. The worsening and reoccurrence of signs and symptoms 
stemming from a wide array of skin diseases have been linked by various studies to stress. 
Together, stress and skin disease synergistically inhibit occupational, social, emotional, and 
physical health and functioning resulting in diminished quality of life (Dixon, Witcraft, & 
Perry, 2019; Salman et al., 2016). This paper will exclusively be looking at the psychological 
effects of acne vulgaris, psoriasis, vitiligo, rosacea, and atopic dermatitis.  
 Heightened levels of stress can contribute to an assortment of immediate and future 
adverse outcomes. Such outcomes include the triggering of a skin outbreak, impaired function, 
behavioral avoidance, intense negative emotions such as shame and embarrassment, and 
depression and anxiety (Dixon et al., 2019). Little attention is given to skin disease in the 
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national and global health debate despite this information and profound impact (Hay et al., 
2013).  The American Academy of Dermatology Association (2020) stated that in 2013 the 
cost of skin disease to the United States (U.S.) health care system was $75 billion.  The price of 
skin disease to the U.S. health care system included preventative, medical, and prescription and 
non-prescription drug costs. 
 In 2010, the World Health Organization (2011) estimated that the global cost of mental 
illness was nearly $2.5 trillion.  They projected this amount would increase to over $6 trillion 
by 2030.  Per the World Health Organization (2011), in 2009, the entire global health spending 
was $5.1 trillion, the very next year in 2010, mental illness alone cost $2.5 trillion globally.  
Almost half of the world’s global health spending has gone towards mental illnesses.  
Depression alone causes a substantial economic burden.  Between 2005 and 2010, the financial 
burden of major depressive disorders in the United States increased from $173.2 billion to 
$210.5 billion (World Health Organization, 2011).   
 In 2006, The Agency for Healthcare Research and Quality cited mental healthcare in 
the U.S. cost $57.5 billion, which was equivalent to the cost of cancer care.  However, unlike 
cancer, the cost of care is not the major cause of the economic burden of mental illness, rather, 
it is the expenses for social support, loss of income due to unemployment, and a variety of 
indirect costs due to a chronic disability (National Institute of Mental Health, 2016). 
 Despite all of this information about the cost and effects of psychological disease, 
anxiety and depression are under-recognized in dermatology clinics by the healthcare team 
(Conner, 2017; Dalgard et al., 2014) and that this under-recognition occurs frequently (Picardi 
et al., 2005).  Further problems that were ascertained through personal communications with 
various dermatologists across the Arizona valley is that dermatologists may feel uncomfortable 
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having to address mental health issues in their patients.  Some dermatologists state it would be 
easier to refer their patients with anxiety or depression back to their primary care provider or a 
therapist than to screen patients and intervene themselves.  Other dermatologists stated they 
feel they just don’t have the time or specialized knowledge to screen for psychological 
disorders and then prescribe interventions. 
Purpose and Rationale 
 The purpose of this paper is to discuss the relationship of stress, anxiety, and depression 
to the specific chronic skin diseases of acne vulgaris, psoriasis, vitiligo, rosacea, and atopic 
dermatitis. It will also discuss how a psychotherapeutic intervention called mindfulness-based 
stress reduction (MBSR) may decrease anxiety and depression in individuals with chronic skin 
diseases.   Finally, this paper will highlight the impact of MBSR on treatment adherence to 
dermatological prescription medications as well as evaluate post-implementation satisfaction. 
This implementation project using MBSR desires to decrease stress levels in patients with 
chronic skin diseases resulting in reduced anxiety and depression. Additionally, the use of 
MBSR postulates that participants will show increased adherence to their dermatological 
medications and find satisfaction in MBSR and the results they obtain. 
Background and Significance 
Skin Disease 
     Skin disease and its sequelae affect people of all races, genders, and ages around the 
world.  Hay et al. (2013) performed a systematic literature review using the skin diseases found 
in the Global Burden of Disease Study 2010. In this review, Hay et al. (2013) found that in 
2010 skin diseases expressed as years lost due to disability were the fourth leading cause of 
nonfatal burden and was the eighteenth leading cause of worldwide health burden.  The 
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American Academy of Dermatology Association (2020) stated that in 2013, 84.5 million 
Americans (one in four Americans) were impacted by skin disease.   
 As the most visible and most considerable organ of the body, the skin has a significant 
effect on physical appearance. Normal healthy skin plays an essential role in the maintenance 
of an individual's physical, social, and mental well-being (Salman, Kurt, Topcuoglu, & 
Demircay, 2016). Studies have suggested that the skin is a significant influencer of self-esteem, 
social relationships, and the development of personality.    
 People with the specific chronic skin diseases of acne vulgaris, psoriasis, vitiligo, 
rosacea, and atopic dermatitis endure higher levels of stress and corresponding social anxiety 
and depression as compared to those without chronic skin disease. Dixon et al. (2019) state that 
33.4–47.5% of dermatology patients experience clinically significant social anxiety, 10.6–
45.8% express health anxiety concerns, and 8.7–40% meet the criteria for a generalized anxiety 
disorder or "pathological worry." Anxiety is well known to cause various general adverse 
outcomes and may even exacerbate some skin disorders. Research on skin disease has shown 
significant associations between higher anxiety symptoms and adverse outcomes, including 
lower self-esteem, stigmatization, worse quality of life, and skin symptom severity (Dixon, 
Witcraft, McCowan, & Brodell, 2018). Interestingly, there may be a direct correlation between 
anxiety and depression. Individuals with high social anxiety levels may also have high levels of 
depression (Gül & Çölgeçen, 2015; Salman et al., 2016). 
 The pathology of dermatological diseases often extends more profoundly than the skin 
itself, ultimately, into the very core of the individual, their mind (Connor, 2017). Depression 
can be a severe psychological issue and is often associated with skin disease. Dalgard et al. 
(2014) performed an observational cross-sectional multicenter study showing that out of 3,295 
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subjects with prevalent dermatological conditions the rates of depression, anxiety, and suicidal 
ideation were 10.1%, 17.2%, and 12.7%, respectively, as compared with 4.3%, 11.1%, and 
8.3% in controls. Interestingly, there is a relationship between skin disease severity and 
depressiveness. Pietrzak et al. (2017) state that in psoriasis patients, higher severity of 
symptoms reflects depressiveness, and also, the presence of skin lesions exacerbates the course 
of depression. Studies state that depression interferes with medication adherence in an array of 
chronic diseases and, thus, negatively affecting treatment outcomes (Pietrzak et al., 2017).  
 A systematic review performed by Patel, Immaneni, Singam, Rastogi, and Silverberg 
(2019) showed that 1 in 6 patients with atopic dermatitis had clinical depression and 1 in 8 had 
suicidal ideation. After synthesizing eight studies on suicidal ideation, Singh, Taylor, 
Kornmehl, and Armstrong (2017) found that patients with psoriasis were more than twice as 
likely to have suicidal ideation than patients without psoriasis. Gül and Çölgeçen (2015) state 
that female patients with acne ages 18-19 years reported suicidal ideation two times more often 
than those without acne and the likelihood increased to three times more often for male patients 
with acne ages 18-19 years as compared to those without acne.  
MBSR 
 A psychotherapeutic method called mindfulness-based stress reduction (MBSR) is 
beneficial for people experiencing a wide range of long-term health conditions, including skin 
diseases. MBSR is a technique developed in 1979 by Dr. Jon Kabat-Zinn. The core of MBSR 
uses guided body scans, yoga exercises, and meditation practices. Initially, MBSR was 
designed exclusively for stress management. However, it has evolved to encompass treatment 
for a variety of health-related disorders, including anxiety, depression, diabetes, hypertension, 
chronic pain, cancer, and skin diseases (Niazi & Niazi, 2011). MBSR has been shown in 
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multiple research studies to be a helpful non-pharmacological intervention in treating these 
various chronic illnesses. A systematic review and meta-analysis showed that MBSR 
demonstrates promising results in the decrease of anxiety and depression in patients with 
chronic diseases such as skin disease (Victorson et al., 2015).  
 Though gaining in popularity due to its growing success in newer research, standard 
medical treatment does not accept MBSR for the prevention or treatment of any illness or 
disease. Niazi and Niazi (2011) note that over 200 medical centers around the world offer 
MBSR as an alternative treatment option to patients with a variety of health-related disorders 
suffering from physical, psychosomatic, and psychiatric disorders. Notably, recent studies 
demonstrate the effectiveness of MBSR on the psychological sequelae from chronic skin 
disease. Montgomery, Norman, Messenger, and Thompson (2016) found higher levels of 
awareness achieved through MBSR to be associated with lower levels of psychological distress 
as well as higher levels of dermatological quality of life in patients with chronic skin disease. 
Montgomery et al. (2016) go on to say that these findings offer evidence that increasing 
mindfulness may help reduce distress, including anxiety and depression, in people living with 
visible chronic skin conditions. Interestingly, one study by Kabat-Zinn et al. (1998) suggested 
that audio-taped guided MBSR practices accelerated the rate of skin clearing in psoriatic 
patients when used in conjunction with their regular treatments. MBSR may have the potential 
to decrease anxiety and depression in dermatological patients as well as improve their specific 
skin condition when added to their skin treatment plan.  
 In-person MBSR programs led by an instructor is the most popular venue for MBSR. 
Attending such programs involves individuals interested in engaging in mindfulness to find a 
class, usually consisting of a larger group of people, and attend it at the pre-scheduled time, as 
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well as find transportation. These difficulties of an in-person MBSR class have led to a demand 
for and creation of an online MBSR class that can be performed at any time, therefore, creating 
greater flexibility for the patient. It is noteworthy to mention that large groups of people in a 
class or completing the standard eight weeks of MBSR intervention are not necessarily needed 
to see positive results. Victorson et al. (2015) provide in their systemic review and meta-
analysis of mindfulness-based randomized controlled trial evidence for MBSR interventions 
with fewer than 20 individuals per group, as well as partial support for interventions that are 
less than the standard eight weeks in duration. Furthermore, research supports the use of 
electronics to deliver successful mindfulness interventions even though the use of other tools is 
more often employed (Victorson et al., 2015). The use of electronics could include mobile 
phone applications or internet-based guided practices via video or audio in which a single 
person may utilize the MBSR application. 
Internal Evidence 
 In a dermatology clinic in the southwestern United States that provides medical, 
surgical, and aesthetic treatments, there is not an established intervention for patients with 
anxiety or depression. The clinic does not routinely screen for anxiety or depression, but they 
do realize the connection between psychological disease and skin disease. There is a great 
desire within this clinic to improve the overall health outcomes of their patients.  
 Using MBSR as part of the clinic's holistic treatment plan for dermatological patients 
may decrease patient anxiety and depression, increase patient adherence to treatment, provide 
better healthcare outcomes for their patients, and increase patient satisfaction. By offering 
MBSR, this clinic would like to improve the overall mental and physical health outcomes of 
their patients with skin disease and see increases in patient treatment adherence. 
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PICOT 
 This inquiry has led to the clinically relevant PICOT question, "In patients with specific 
dermatological diseases of acne vulgaris, psoriasis, vitiligo, rosacea, or atopic dermatitis (P), 
how does an online mindfulness-based stress reduction program (I), using the same group pre 
and post-intervention (C), affect treatment adherence, anxiety, depression, and satisfaction (O) 
over four weeks (T)? 
Search Strategy 
 An exhaustive search of the following electronic databases was conducted to answer 
the previously discussed PICOT question. The databases searched for the literature review 
included PsychINFO, Allied Health Literature (CINAHL), PubMed, and the Cochrane Library. 
Keywords included; skin disease, skin, disease, chronic, dermatology, acne vulgaris, psoriasis, 
vitiligo, rosacea, atopic dermatitis, eczema, treatment adherence, adherence, holistic, 
mindfulness, mindfulness-based stress reduction, MBSR, meditation, yoga, awareness, stress 
reduction, stress, psychological distress, anxiety, depression, psychological, and suicide. The 
initial search of disease and MBSR yielded 41 results in CINAHL (Appendix A, Figure A.1), 
116 in The Cochrane Library (Appendix B, Figure B.1), and 80 in PubMed (Appendix D, 
Figure D.1), all had limits set to English language, humans, any age, publication date from 
2013-2019. PsychoINFO was used to search for skin disease and depression and anxiety, 
yielding 88 peer-reviewed articles (Appendix C, Figure C.1). Combination words of skin, 
disease, dermatology, and chronic were used in PubMed and CINAHL, as well as various 
combination key words using anxiety, depression, and psychological disorder and mindfulness-
based stress reduction, MBSR, yoga, meditation, skin, disease, chronic. A separate search 
of holistic, skin, skin disease, dermatology, adherence, and treatment adherence using an 
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exclusion criterion of articles published within the last five years (Appendix A, Figures A.2, 
and Appendix D, Figure D.2).   
 The Boolean connector "or' and "and" were utilized for the main features of the PICOT 
question, including population, intervention, and outcome. Unpublished works, though 
reviewed, were regarded as inappropriate for this review. Gray literature was reviewed with no 
acceptable yields, and hand searching of references was utilized yielding two studies. Included 
studies involved all people aged 15 years and older, specialty, and community settings in 
various countries. An extensive review of the literature led to a large yield of articles that was 
narrowed down to seventeen relevant articles and one professional opinion paper in which 
research evidence and information were gleaned from for use in this paper. Four of the 
seventeen studies acted as an auxiliary for each of the four survey tools used in the project 
implementation discussed in this paper. One article supports the evidence-based practice 
model, and one article supports the conceptual model, which are both used to guide this paper. 
Of the thirteen remaining research articles that correlated with this paper, ten were considered 
the best evidence for the examination of this PICOT question and placed in an evaluation table 
for the analysis of external evidence (Appendix E).  
Critical Appraisal and Synthesis 
 Seventeen research studies and one professional opinion paper were included in this 
literature review.  All research studies were evaluated using Melnyk and Fineout-Overholt's 
rapid critical appraisal. The best ten articles were chosen to be used for synthesis and 
evaluation (Appendix E and Appendix F). Six of the ten studies that best answered the PICOT 
question were cross-sectional, creating lower levels of evidence. Of the final ten studies, there 
were six cross-sectional studies, of which two were Level II, and four were Level III, and four 
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systematic review studies were included as well (Level I) (Appendix E).  Five of the research 
studies looked specifically at the benefits of MBSR; One was a systematic review that 
evaluated the effects of MBSR on various types of chronic diseases and the other four showed 
a relationship between MBSR and chronic skin diseases only.  The other five articles discussed 
anxiety, depression, or stress in patients with chronic skin disease. 
 Most of the studies included minimal bias except for two studies in which one author 
had a professional correlation with the research in some aspect, and the other article had a 
study outcome that was not assessed blindly (Appendix E). Only two of the studies defined a 
conceptual framework. Having an established conceptual framework is essential to recognize 
because these structures help guide the researcher in multiple ways throughout the study. For 
instance, frameworks help to determine if the demonstration of the relevance and need for the 
research is satisfactory. They also aid in establishing a persuasive line of reasoning and 
absolute academic rigor in the development of the design and analysis. Undefined conceptual 
frameworks were extrapolated by observing the repetition of topics and themes within the 
article. Additionally, some articles provided metaphors and analogies with underlying themes 
that were deduced through analysis.   
 The majority of the ten research studies included heterogeneous research groups in that 
they encompassed men and women from all ages greater and equal to fifteen years. However, 
the rest were homogeneous because most participants were non-African American and of 
lighter colored skin types such as Caucasian, Turkish, or Indian. Seven of the articles were 
conducted outside of the United States, significantly decreasing generalizability (Appendix F). 
However, most of these studies either had a large sample size, a high level of evidence, or were 
congruent with previous similar research (Appendix E). Of the six articles that were not 
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systematic reviews, two of them had a consistent weakness of small sample sizes. The 
strengths of small studies are that they can be quick to conduct, usually do not cost as much as 
more extensive studies, and they can often address a research question in a relatively short 
amount of time. However, if an association is found, it is important to make clear in the 
conclusions or discussion that it was from a hypothesis-generating study, and more extensive 
confirmatory research is needed, which each article with this specific limitation did note.  
 Nevertheless, the results of these ten studies are transferable to those people with a 
chronic skin disease who are patients of a dermatology clinic.  All studies involved participants 
specifically with chronic skin disease. The systematic reviews analyzed and reviewed studies 
that utilized participants with chronic skin disease. The majority of participants in the chosen 
ten studies were either under current dermatological care or had seen a dermatologist in the 
past regarding their current skin condition. Additionally, to evaluate the participants for a 
mental disorder, a questionnaire or specialist evaluation was used.   
 All the studies had strict inclusion and exclusion criteria, which translated into the 
strength of the study (Appendix E). Also, the majority of the studies found at least one 
significant result of p<0.05 regarding the variable they were studying. Additionally, nine of the 
articles had results that were congruent with previous research, and one article found partial 
congruence in their results as compared with previous research. 
 There were different variables used throughout multiple studies, including anxiety, 
depression, quality of life, MBSR, meditation, acne vulgaris, psoriasis, vitiligo, rosacea, and 
atopic dermatitis (Appendix F). Out of the ten chosen articles used in synthesis and evaluation, 
two discussed depression and skin disease, two discussed anxiety and skin disease, three 
discussed both depression and anxiety and skin disease, and three discussed MBSR and skin 
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disease.  Interestingly, in the five studies looking at depression, only three used the same 
depression survey, HADS (Appendix E). It is often difficult to correlate results from various 
articles when they use different questionnaires and scales of measurement.   
 All the ten studies found a significant relationship between at least one of their 
independent variables with the dependent variable. Most of the studies used observational 
techniques and researcher-developed questionnaires, while a few of them used tested 
measurements and instrumentation (Appendix E). There were various measurement tools used 
(Appendix F).  
 Since several variables were tested amongst multiple study topics, different 
measurement tools were used. There is research lacking in the study of MBSR used as an 
intervention specifically to skin disease. A few of the articles opted to use several forms of 
non-validated questionnaires, making the reliability and validity of the results difficult to 
ascertain.  
 A majority of the research articles used the statistical package for social sciences 
(SPSS) to analyze their data (Appendix E). Interestingly, these ten studies used a variety of 
statistical tests to determine outcomes. For example, half of the ten studies used some version 
of SPSS to analyze data. The other five articles used either DisMod-MR, OpenMeta, Chi-
square, Fisher's exact, Mann-Whitney and Wilcoxon, Student's t-test, Spearman Correlation, 
and Pearson's correlation (Appendix E). Noticeably, only one of the four systematic reviews 
used SPSS.  
 These ten studies show that chronic skin disease can cause various levels of depression 
and anxiety, affecting multiple aspects of one's life. Though no direct causation can be made, 
findings of these studies show that there is a negative correlation between MBSR and anxiety 
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and depression, as well as a direct relationship between chronic skin disease and both anxiety 
and depression. Studies have shown that stress is widespread and significant in people with 
chronic conditions, including skin disease. From this stress, anxiety and depression can occur. 
 Additionally, certain psychological disorders can decrease treatment adherence causing 
more negative patient outcomes. Evidence-based research suggests that MBSR could be 
successful in reducing anxiety and depression so often seen in patients with chronic skin 
disease, improving treatment adherence, decreasing stress, anxiety, and depression, and 
ultimately improving patient outcomes.  
Foundational Influence from Synthesis 
 Research synthesis has shown that MBSR is beneficial in many types of chronic 
diseases, including chronic skin disease.  The synthesis of the research has shown that only a 
select few chronic skin diseases have been studied in research concerning MBSR.  No research 
was found evaluating the effects of MBSR on acute or intermediate skin care issues or 
diseases.  The chronic skin diseases that have been considered in analysis with MBSR are acne 
vulgaris, psoriasis, vitiligo, rosacea, or atopic dermatitis.  Therefore, this project 
implementation only includes participants with one or more of these chronic skin diseases 
shown in research to benefit from MBSR.   
 Additionally, the synthesis of research has stated that the standard MBSR program is 
eight weeks long.  Studies have shown a more significant impact on participant outcomes using 
extended MBSR programs. However, due to time constraints, this project was conducted over 
four weeks. Yet, research synthesis provided partial support for MBSR interventions that are 
less than the standard eight weeks in duration. 
Conclusions 
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 Clinicians have a persistent desire to care for patients in the best way possible. This 
paper intends to explore the possibility of using MBSR to decrease the anxiety and depression 
often found in patients with a skin disease as well as increase treatment adherence. In 
achieving these outcomes, clinicians can aid their patients in reducing psychological distress, 
thereby caring more holistically for the patient.  
 Research establishes the positive impact of MBSR as a non-pharmacological 
intervention for various types of chronic diseases. Evidence suggests that a higher level of 
mindfulness can result in decreased anxiety and depression. It has also eluded to the possibility 
that MBSR can accelerate the rate of skin clearing in certain chronic skin diseases.  
 There are advantages to an online MBSR program. Firstly, there is little risk involved 
with performing MBSR.  Secondly it is cost effective as it can be found for free online. 
Thirdly, it can be easily accessed and learned by patients, and patients can use these learned 
skills for all types of stress and anxiety experienced in their daily lives. Fourthly, and 
ultimately, MBSR may create an overall enhancement in patients' quality of life. Treating the 
whole patient, including assessment of their psychological status as well as providing a 
psychotherapeutic intervention if needed, can help patients in multiple ways. This type of 
holistic care and intervention can decrease patient stress, anxiety, and depression, increase 
medication and treatment adherence, produce more positive patient outcomes, and ultimately 
improve overall patient satisfaction with treatment and results. 
EBP Model and Conceptual Model 
 The ACE Star Model of Knowledge Transformation (ACE) is an evidence-based 
practice (EBP) model that provides a framework to help understand the relationship between 
various stages of knowledge transformation (Bonis, Taft, & Wendler, 2007). Each point of the 
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star represents a transformation of knowledge (Figure G). Moving from one point of the star to 
the next allows EBP to be placed into the proper aspects of this project's context. 
 Knowledge discovery represents new knowledge that is discovered through both 
qualitative and quantitative studies found through empirical research. The evidence summary 
shows how research is synthesized regarding a problem. Research that is summarized is 
combined with other sources of evidence such as clinical expertise, and this extensive evidence 
is translated into the specific population, which makes up the point of the star called translation 
into practice recommendations (Bonis et al., 2007). This paper has executed an exhaustive 
search of literature regarding the correlations between anxiety and depression, skin disease, 
and MBSR. The most relevant research with the most exceptional levels of evidence has been 
evaluated to be implemented in this paper and project. The ACE explains how knowledge from 
this exhaustive literature search is converted into a viable and practical psychotherapeutic 
intervention. The ACE also explains how MBSR affects the health outcomes of those with skin 
disease.   
 Integration into practice stands for the implementation of practice change through 
informal and formal methods. The application of MBSR is the practice change utilized in this 
project to decrease patient anxiety and depression. It is also applied to increase treatment 
adherence. Finally, the last point of the star is an evaluation, which includes evaluating the 
practice change on the outcomes of patients and patient satisfaction (Bonis et al., 2007). At the 
end of this four-week MBSR intervention, participants will be given repeat surveys along with 
a satisfaction survey to evaluate outcomes and participant satisfaction.  
 The ACE provides concepts that are important to foster investigation and reasoning 
regarding the psychological stress surrounding the various factors affecting or affected by skin 
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disease. It helps explain how research is collected, reviewed, and applied towards an 
intervention. This model delivers a framework for systematically putting evidence-based 
research into practice through the application of practice processes. It helps explain how 
research studying MBSR applied as an intervention for anxiety and depression in chronic skin 
disease patients is collected and reviewed. 
 The ACE explains the nature of the knowledge needed to transform current practice. 
Bonis et al. (2007) state that knowledge becomes increasingly more useful and useable within 
patient care as it is translated into the next stage. It is essential to understand all types of 
research, and put that research together through examination, review, and synthesis, and apply 
it comprehensively to patients with skin disease. This model is useful in the development of 
MBSR as a psychotherapeutic intervention for those with chronic skin disease because it 
depicts the various stages of knowledge transformation as newly discovered knowledge is 
moved into practice. Much of the research used to create this implementation project is 
relatively new and not widely studied. This model helps incorporates previous scientific 
evidence-based research as well as new evidence-based research.  
 The guiding theoretical framework for this research paper is the Self-Efficacy 
Theory (SET). Taken from social cognitive theory, SET was originated by Alberta Bandura. 
Self-efficacy is the belief that one has the power to complete a given activity or task related to 
competency (Bandura, 1977). The ability of a patient's perception of being able to reach their 
skin disease management goal is vital for patient adherence, the best patient health outcomes, 
and a decrease in anxiety and depression. The deliverance of the SET can explain the possible 
increase of self-esteem in patients with skin disease and a pursuant increase in self-efficacy. 
The SET is being used in this research as an effort to understand and drive behavior change of 
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psychological disorder through the rise of patient self-efficacy from engaging actively in 
MBSR.  
 The three factors that influence self-efficacy are behavior, personal and cognitive 
factors, and environment (Bandura, 1977) (Appendix H). Though different concepts, Bandura 
(1997) states that self-efficacy and self-esteem are related. As self-efficacy increases, so too 
does self-esteem.  The thought is that MBSR, which produces positive patient outcomes of 
decreased psychological distress, will increase patient self-efficacy, and therefore, their 
treatment adherence will increase.  This will ultimately improve patient outcomes and therefore 
increase patient psychosocial attitudes and self-worth. The SET suggests that self-efficacy 
develops from mastery in experiences and understanding of a regimen in which the patient is 
directed and given the ability to overcome obstacles (Bandura, 1977).  
 The SET is useful to guide practitioners in using a regimen, such as a MBSR program, 
to empower the patient to overcome any worries or frustrations associated with previous 
treatment failures and to eliminate any negative preconceived notions of skin disease and its 
management. Having these patients learn MBSR will theoretically provide them the ability to 
utilize stress reduction tools that will empower them to work through their stress and decrease 
their anxiety and depression. Furthermore, since depressiveness is widely known to interfere 
with medication adherence (Connor, 2017), one would also presume as the patient's 
psychological symptoms decrease, that their skin disease medication adherence will increase, 
causing an improvement in their skin condition. The patient would additionally experience 
improved psychosocial attitudes and self-worth from this improvement in skin condition.  
 Behaviors, such as treatment adherence, self-esteem, anxiety, and depression, are 
determined by motivation, feelings of frustration, and performance of treatment regimens 
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(Bandura, 1977). SET is being used as the conceptual framework to understand how behavior 
change increases patient self-efficacy. Once patients are empowered to adapt to MBSR and 
learn tools to combat stress and anxiety in their daily lives, they will experience an increase in 
self-efficacy, which will increase treatment adherence and provide increased positive patient 
healthcare outcomes.  
Methods 
 A pilot program was conducted in the Fall of 2020 over a four-week time frame in a 
dermatology practice clinic in the southwestern United States. This project utilized two of the 
dermatology clinic’s locations in Arizona, one in Phoenix and one in Scottsdale.  Both sites 
provide medical, aesthetic, and surgical treatments for patients.  The key stakeholders include 
the clinic, nurse practitioner, other providers, front office staff, advanced practice nursing 
(APN) student, patients, and family/caregivers. Multiple adult patients aged eighteen years or 
older who are currently under pharmacological treatment, or no treatment, or using any 
physical modality or not, or are either on or off an antidepressant or an anti-anxiety medication, 
are included in this project implementation. Other inclusion criteria: Prospective participants 
are; established with the dermatology clinic, identified by the clinic nurse practitioner (NP), 
speak and read English, have a documented diagnoses of acne vulgaris, psoriasis, vitiligo, 
rosacea, or atopic dermatitis, and has access and ability to use a personal e-mail account. 
 The APN student conducted multiple weekly clinic visits for two weeks to recruit 
participants.  The APN student explained the project, MBSR logs to record daily practices, 
surveys, and consents to each eligible patient.  Eligible patients completed consent, baseline 
surveys, a demographics form, and provided an e-mail address. The baseline surveys include 
Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder (GAD-7), and possibly a 
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Dermatologist Directed Questionnaire (DDQ). The specific demographics obtained from 
participants included ethnicity, age, comorbidities, use of antidepressants, anti-anxiety 
medications, or prescription dermatological medications, and participants' previous experiences 
with MBSR, and health insurance.    
 Many methods are available to assess anxiety and depression. However, one quick, 
effective, and validated tool used to measure depression in a clinical setting is called the 
Patient Health Questionnaire (PHQ-9). The PHQ-9 is a valid survey tool to measure 
depression. It has a sensitivity of 75.7% and a specificity of 80.0% when used to measure 
depression levels in diabetic patients at an outpatient clinic (Van Steenbergen-Weijenburg et 
al., 2010). 
 Additionally, the Generalized Anxiety Disorder (GAD-7) questionnaire is also a quick 
and validated tool to measure anxiety levels in a clinical setting. In a study conducted in the 
general population by Löwe et al. (2008), the GAD-7 has a sensitivity of 89% and a specificity 
of 82% in diagnosing a generalized anxiety disorder.   
 The Likert scale is a validated tool that this project utilizes to measure patient post-
intervention satisfaction with MBSR. The sensitivity and specificity of the Likert scale is 80% 
and 89.5%, respectively (Koksel et al., 2019). 
 This project measures adherence to oral and topical acne treatments via the 
Dermatologist Directed Questionnaire (DDQ), the mini-questionnaire versions. One version of 
the DDQ is specific to oral therapy, and the other DDQ is specific to topical treatment. Both 
DDQs consist of four questions. Both mini-DDQs have a sensitivity of 0.47 and a specificity of 
0.89 (Pawin et al., 2009). Unfortunately, this tool has yet to be validated. However, there were 
no other adherence tools specific to skin disease found in the current literature. The DDQ is the 
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only tool used in this project that is not of the public domain. Dr. Pawin, the lead creator of the 
topical and oral DDQs, has given this project written permission via e-mail to use both DDQ 
questionnaires. 
 Initially, ten female participants agreed to enroll in this project intervention.  These ten 
participants received weekly informational e-mails instructing them on what MBSR practices 
to engage in for that week, along with a few words of encouragement from the APN student. 
Participants derived the MBSR practices from a free online MBSR website that they were able 
to access at any time of their choosing. A MBSR log was attached to each participants’ first e-
mail.  Participants were encouraged to engage in MBSR practices daily.  Participants were 
instructed to record the date, type of MBSR practice they engaged in, and any additional 
comments onto their MBSR log.   
 After three weeks of the project implementation, one participant dropped out.  At the 
end of the four-week project implementation, the remaining participants received a repeat of all 
baseline surveys via e-mail, with the addition of a Likert satisfaction survey.  Participants were 
re-instructed to complete and turn in their online surveys and MBSR log.  After one week, non-
compliant participants were reminded via e-mail to complete and turn in their online surveys 
and MBSR log.    
 Upon the completion of the project and after a reminder e-mail, only three participants 
completed and returned all of their post-intervention surveys and MBSR log.  The three 
participants comprised of females ages twenty-five, thirty, and fourty years; two Caucasians, 
and one Hispanic; and current diagnosis of a chronic skin disease of rosacea, acne vulgaris, and 
vitiligo respectively.  All participants had previously engaged in some form of MBSR: two had 
tried yoga and one performed meditation.  One participant had been taking anti-anxiety and 
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anti-depression medications for “years”.  This particular participant was the only one to have 
other co-morbidities of: Irritable bowel syndrome, attention deficit disorder, anxiety, and 
depression.  All other participants denied any co-morbidities.  One participant was currently 
using prescription topical medications for their skin disease. All participants had active 
insurance. 
Human Subject Protection 
 During initial recruitment, the APN student instructed all eligible participants that they 
may opt-out of the project at any time, and they may refuse to answer any question with which 
they are not comfortable on any survey or paperwork for the project.  The consent for the 
project also contained this information.  A four-digit code of patients’ first two letters of their 
first name followed by their birthday month in two-digit format was linked to all MBSR log, 
surveys, demographics, and e-mail addresses in Qualtrics (survey program). All e-mails that 
sent to the participants utilized their four-digit identifier code.  All e-mails were sent to the 
participants via the APN student’s school e-mail account, which required password and ID 
name protection.  Additionally, all data from Qualtrics employed the participant four-digit 
code.  The contact field was changed in Qualtrics so that only the external reference could be 
viewed.   
 Once the data was collected, the APN student placed all de-identified data from 
Qualtrics into a de-identified master datasheet.  When all data was collected, this master data 
sheet was printed and immediately locked in a file cabinet in the APN’s home office and was 
only accessible by the APN student.  After all information and data were retrieved from 
participant e-mail, the APN student destroyed all patient e-mails as well as any electronic 
MBSR logs. As soon as all information and data were extracted and analyzed and outcomes 
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were measured, the APN student destroyed all surveys and participant information, e-mail 
addresses and e-mails, MBSR logs, data, and surveys and e-mail addresses on Qualtrics.  
The master list and consents only existed until project completion, May of 2020. Once the 
outcomes were measured and evaluated, the master list and consents were destroyed.  No 
digital copies of the master list, consents, or any other part of this project were kept at any 
time.  
 This project did consist of a particular intervention detail.  If either a participant’s pre 
or post PHQ-9 or GAD-7 survey totaled ten or higher, or if there was any positive answer to 
question number nine of the PHQ-9, “Thoughts that you would be better off dead or of hurting 
yourself in some way,” the APN student would speak to the NP either at that time (found 
during pre-survey) or the APN student would call the NP (discovered during post-survey) for 
immediate referral, and have the dermatology clinic NP decide on the referral course of action.  
Consents contained the participants’ four-digit code and names and would only be accessed 
upon findings of an abnormal PHQ-9 or GAD-7 survey results.  IRB approval from Arizona 
State University for this project implementation was received on December 21st, 2019.  
Data Collection and Analysis Plan 
Budget and Funding 
 This project was managed and implemented solely on awarded grant funding and in-
kind donations. Other grant funding was provided by Arizona Dermatology and by involved 
individuals who donated their time to the project. As need dictates, the dermatology clinic is 
willing to aide in the sustainability of the program by continuing support and funding after the 
project intervention period comes to an end (Appendix I.1 to I.4).  Additionally, participants 
who turned in their MBSR log and surveys at the end of the four-week project intervention 
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received a ten dollar Starbucks gift card.  Ten dollars is generally considered an appropriate 
“Thank you” amount, and it is not coercive.  The money for these gift cards was provided for 
by the APN student. 
Results 
Outcomes and Clinical Significance 
 Statistical analysis of the project data has limited power due to small sample size.  Due 
to the small sample size, other relevant statistical analyses, such as the effects of MBSR on 
medication adherence, and the relationship of the frequency of performed MBSR exercises to 
outcomes, could not be established.   
 A two-tailed Wilcoxon signed-rank test was conducted through Intellectus to examine 
whether there was a significant difference between GAD-7 and PHQ-9 pre and post scores.  
The results of the two-tailed Wilcoxon signed-rank test for GAD-7 scores were not significant 
based on an alpha value of 0.05, V = 4.00, z = -0.58, p = .564.  The results of the two-tailed 
Wilcoxon signed-rank test for PHQ-9 scores were not significant based on an alpha value of 
0.05, V = 4.50, z = -0.82, p = .414.  These results indicate that the differences between GAD-7 
and PHQ-9 scores are both explainable by random variation.   
 However, though not statistically significant, results are clinically significant.  All 
participants showed a decrease in pre and post GAD-7 and PHQ-9 scores and subjective 
symptoms after engaging in the MBSR intervention.  Of particular interest is that one 
participant had been taking anti-anxiety and anti-depression medications for at least three 
years.  This participant showed a reduction in both anxiety and depression symptoms and 
survey scores.  This participant showed the greatest decrease in GAD-7 pre and post scores.   
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 All participants reported enjoyment using MBSR, stated they would continue using 
MBSR,  agreed their skin condition improved with MBSR, and indicated they had a reduction 
in their anxiety/depression symptoms after MBSR. Quotes from participants MBSR logs: “I am 
sleeping better after using MBSR,” “I felt less stressed after doing my meditation,” “…easier 
to fall asleep,” “I enjoyed the stretching,” “Felt my mood shift a bit after this to a more positive 
mindset,” “It was really relaxing to me,” and “I feel calmer after trying visualization.”  The 
biggest barrier to engaging in MBSR practices was collectively agreed upon by the participants 
as finding time in the day.   
Implications and Sustainability 
 The literature agrees that anxiety and depression are prevalent in patients with chronic 
skin diseases and that dermatology providers frequently under-recognized these psychological 
disorders.  This information leads to the implication that perhaps there is a role for 
psychological screening for patients with chronic skin diseases who visit dermatology clinics.  
Dermatology clinic policy will have to change to enforce this and establish protocols to 
distinguish which patients to survey, to establish the types of surveys used, and to layout an 
intervention and referral plan.   
 Due to the prevalence and impact of anxiety and depression in patients with chronic 
skin disease, providers should, at the very least, inquire as to the psychological disposition of 
their patients.  The dermatologist can then ask further questions as appropriately needed.   
 Screening for psychological disorders such as anxiety and depression are just as 
important as screening for diabetes, high blood pressure, and other physical diseases.  
Screening is the first step in getting help for patients.  Anxiety and depression can be severe 
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illnesses within the dermatological population.  As research has shown, they can also 
complicate other medical conditions and even lead to suicide.   
 There is a clinical gap in many dermatology offices in both the screening of chronic 
skin disease patients and available options for timely, appropriate interventions.  Providing 
screening and support options such as referrals and MBSR for patients with chronic skin 
disease is vital to help dermatological patients adjust psychologically in a positive manner to 
the sequelae of their skin disease.   
 A noteworthy implication is that screening and supporting patients with chronic skin 
disease suffering from anxiety and depression may help build a business case for increased 
access to psychological services within dermatology clinics (Lamb et al., 2017).  Additionally, 
screening and supporting patients with chronic skin disease would improve patient access and 
intervention to behavioral healthcare within a specialty setting.   
 MBSR has been shown in research to decrease anxiety and depression in 
chronic skin disease patients.  All three participants in this project intervention showed a 
decrease in both their anxiety and depression after the implementation of an online MBSR 
program.  Dermatologists can comfortably and quickly provide MBSR.  Furthermore, ancillary 
staff can educate patients on MBSR, thereby avoiding interruption of the providers' daily 
workflow. 
 Once anxiety and depression are recognized in skin disease patients, MBSR can be 
used in conjunction with other interventions.  Through screening and intervening, patients will 
likely feel better, increase medication adherence, have lower levels of anxiety and depression, 
show improved medical outcomes, all resulting in improved satisfaction with treatment. 
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 Sustaining the MBSR project requires the dermatology clinic to either screen their 
patients or, at the very least, initiate a discussion with their patients about anxiety and 
depression.  The site will have to keep offering their patients information and education 
regarding MBSR.  Providers and clinic staff will need to be educated on MBSR, and pamphlets 
would be necessitated for ease of patient education.  A company protocol regarding screening 
and intervention would need to be established for MBSR sustainability.   
Discussion 
Limitations 
 The first apparent limitation to this study is that only three participants completed the 
project.  Lack of participants made descriptive data analysis inept, and it precluded any chance 
of resultant correlations or significance through analysis.  Additionally, all three participants 
were female and had self-reported mild skin symptoms.   
 Part of this project was to look at the effects of MBSR on medication adherence. 
However, no data analysis was able to be performed regarding this as only one participant was 
currently taking oral prescription medication.  Furthermore,  that same participant was the only 
participant who was presently taking anti-anxiety and anti-depression drugs, again, not 
allowing for any type of analysis or comparisons to be made. 
 The MBSR online program was set up for the participants so that they could perform it 
at home at a time of their convenience.  However, this method did not create accountability for 
the participant, and it was based on the honor system as there was no program to track the 
number of completed practices.   
 This project did not, however, have complete blinding of participants; they knew the 
purpose of the project and the desired end goal.  The samples were drawn from one specialized 
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dermatology clinic.  By including participants from only one clinic site, boundaries on the 
generalizability of any results are created.     
Recommendations for Future Research 
 Though the findings of this project were not statistically significant, each participant 
did show a decrease in both their anxiety and depression levels after the MBSR intervention 
and stated they had decreased skin condition symptoms.  This decrease in anxiety and 
depression from engagement in MBSR practices does agree with previous research.  However, 
future studies should use a MBSR program in which the participants’ involvement in each 
exercise can be monitored.  A more significant number of participants, both male and female, 
and with a greater variety of skin disease severity should be used.   
 As research has stated, many dermatology clinics under-recognized anxiety and 
depression issues in their patients.  As evidenced by this project clinic site, no psychological 
screening or communication about anxiety and depression is performed with chronic skin 
disease patients.  Therefore, future studies should examine the benefits of a clinic protocol for 
screening and for anxiety and depression in patients with chronic skin disease. 
 Future research should also use multi-sites for recruiting possible participants.  It would 
additionally be beneficial to glean clinician ratings of skin severity to evaluate the effects of 
MBSR on the outward signs of chronic skin disease.  Finally,  future studies need to look at a 
greater variance of ethnicities.  It is advisable to look at and evaluate participants' quality of life 
and get participants who are on chronic skin disease medication to assess the impact of MBSR 
on medication adherence.   
 This project did, however, find two important considerations for future studies to 
continue to utilize.   First, it was found very beneficial to have the participants record their 
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subjective comments after engaging in a MBSR exercise.  Obtaining participant subjective 
comments provides greater insight into the immediate benefits of MBSR.  Secondly, the 
evaluation of participant satisfaction to the MBSR program proved valuable.  Having 
participants complete a satisfaction survey after a MBSR program intervention provided a 
better understanding of how participants felt about the program overall.  A satisfaction survey 
may expose the weaknesses and strengths of the MBSR program, aid in supporting the results 
of the MBSR program, and better understand the benefits MBSR provided the participant.    
Summary 
 Psychological stress is prominent in patients with chronic skin disease.  Stress can 
result in adverse outcomes for patients with chronic skin disease, including anxiety and 
depression.  Patients with chronic skin disease have increased levels of anxiety and depression 
as compared to patients without chronic skin disease.  MBSR is a psychotherapeutic 
intervention that providers can comfortably and efficiently provide to their patients.  Patients 
can learn MBSR on their own and use the skills they acquire from it to combat all types of 
stressors.   
 Implementation of this pilot program in a dermatology clinic showed that patients with 
chronic skin disease experienced a reduction in anxiety and depression survey scores and 
symptoms after engaging in MBSR.  MBSR has the potential to help patients manage their 
daily stressors better, increase their treatment adherence, and provide for them better overall 
outcomes and satisfaction levels.  
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# - number, aa – alopecia areata, ad – atopic dermatitis, AN – Asian,  anx – anxiety, AS – anxiety sensitivity, ASI-3 – Anxiety Sensitivity Index-3, asses – assessment, AV – acne vulgaris, B – Black, BDI – Beck Depression 
Inventory, betw – between, conco – concordance, dep – depression, derma(s) – dermatologist(s), derm – dermatology,  diff – different, DLQI – Dermatological quality of life scale, d/o – disorder, ds – disease, du – decubitus 
ulcer, dx – diagnosis, F – female, fsd – fungal skin disease, f/u – follow-up, HADS – Hospital Anxiety & Depression Scale, improv – improvement, info – information, instr – instruction, k – Kohen’s Kappa, lit – literature, M – 
male, MBSR – mindful-based stress reduction, mc – molluscum contagiosum,  med – medication, MTurk – Amazon’s Mechanical Turk through TurkPrime, neuro – neurological, NF – nonfatal, nmsc – non-melanoma skin 
cancer, NOS – Newcastle-Ottawa Scale, NR – non-randomized, outpt – outpatient, PICOS - Population, Interventions, Comparators, Outcomes, Study Design, PRISMA – preferred reported items for systematic reviews and meta-
analysis, psych – psychosis, psycho – psychological, pt(s) – patients(s),  QOL – quality of life, RCTs – randomized controlled studies – sig – significance, SD – skin disease, SI – suicidal ideation, sig – significant, ST – short 
term, tx – treatment, UK – United Kingdom, underes(d) – underestimate(d), USA – United States of America val – validated, vw – viral warts, W – White, yr(s) – year(s), wks - weeks 
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Appendix E 
Table 1 
Evaluation Table 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method/ 
Purpose 
Sample/Setting 
 
Major Variables 
Studied and 
Their Definitions 
 
Measurement/ 
Instrumentation 
 
Data 
Analysis 
Findings/ 
Results 
 
Level of evidence/ 
Decision for Use/Application to 
Practice 
Dalgard et. al, 
2018. 
Dermatol-
ogists across 
Europe 
underestimate 
depression & 
anxiety: results 
from 3,635 
dermatological 
consultations 
Country: 
Europe 
 
Funding: 
None 
  
Bias: none 
reported 
Social and 
behavioral 
science theory  
Design:  
Observational 
cross- 
sectional 
multicenter 
study 
Purpose:  to 
estimate the 
concordance 
between 
clinical 
assessment of 
dep and anx 
by a derma 
and ass with 
the HADS 
 
N = 3,635 
Demographics: 
Not disclosed 
Setting:  13 outpt 
derm clinics in 
Europe 
Inclusion: 
-read/write local 
language 
 -not having severe 
pscyh 
-18 yrs & older 
Exclusion: 
-< 18 years 
-non-derm pts 
IV: dep 
IV: anx 
DV: HADS 
 
Time frame of the 
intervention – 
11//2011 to 2/2013 
 
 
HADS to 
measure anx & 
dep 
 
SPSS 24 
K 
Fleiss 
High conco 
betw dermas 
& HADS 
when no dep 
(79.7%) & no 
anxiety 
(70.8%).  
Dermas 
underes dep 
in 5.8% of 
consults and 
anx 11.2% 
Level of Evidence: II 
Strength: high # of consults, results 
were significant. 
Weakness: did not disclose severity 
of pt skin disease, pt reported anx & 
dep, no detailed instr to dermas to 
assess anx or dep 
Conclusion: significant results of 
this study agree with previous 
literature and studies & showed 
dermas in Europe underestimate 
mood d/o’s 
Dixon et. al, 
2018.  Stress 
and skin 
disease quality 
of life: The 
moderating 
role of anxiety 
sensitivity 
social concerns 
Stress and 
adaptation 
model 
Design: 
Cross 
sectional  
Purpose: 
gain insight 
into pscyho 
factors 
affecting SD, 
examining 
N = 237 
Demographics: 
M = 76, F = 161, 
over 18 yrs 
Setting: online 
Inclusion: 
 -over 18 yrs 
-speak and read 
English 
IV: AS  
 
DV: SD 
DV II: stress 
DV III: QOL 
 
Time frame of the 
intervention –
several wks 
MTurk 
ASI-3 
Skindex-16 
SPSS 
statistics 
version 23 
PROCESS 
macro for 
SPSS 
version 
2.16.1 
Sig level 
Decreases in 
AS result in 
increased 
psychological 
well-being 
Level of Evidence: III 
Strength: sig results, results 
congruent with previous studies,  
Weakness: self-reported measures, 
SD not verified by physician,  
Conclusion: results suggest 
decreasing AS improves 
psychological well-being and breaks 
skin symptom and stress cycle in 
MBSR USE IN CHRONIC SKIN DISEASE 
# - number, aa – alopecia areata, ad – atopic dermatitis, AN – Asian,  anx – anxiety, AS – anxiety sensitivity, ASI-3 – Anxiety Sensitivity Index-3, asses – assessment, AV – acne vulgaris, B – Black, BDI – Beck Depression 
Inventory, betw – between, conco – concordance, dep – depression, derma(s) – dermatologist(s), derm – dermatology,  diff – different, DLQI – Dermatological quality of life scale, d/o – disorder, ds – disease, du – decubitus 
ulcer, dx – diagnosis, F – female, fsd – fungal skin disease, f/u – follow-up, HADS – Hospital Anxiety & Depression Scale, improv – improvement, info – information, instr – instruction, k – Kohen’s Kappa, lit – literature, M – 
male, MBSR – mindful-based stress reduction, mc – molluscum contagiosum,  med – medication, MTurk – Amazon’s Mechanical Turk through TurkPrime, neuro – neurological, NF – nonfatal, nmsc – non-melanoma skin 
cancer, NOS – Newcastle-Ottawa Scale, NR – non-randomized, outpt – outpatient, PICOS - Population, Interventions, Comparators, Outcomes, Study Design, PRISMA – preferred reported items for systematic reviews and meta-
analysis, psych – psychosis, psycho – psychological, pt(s) – patients(s),  QOL – quality of life, RCTs – randomized controlled studies – sig – significance, SD – skin disease, SI – suicidal ideation, sig – significant, ST – short 
term, tx – treatment, UK – United Kingdom, underes(d) – underestimate(d), USA – United States of America val – validated, vw – viral warts, W – White, yr(s) – year(s), wks - weeks 
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Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method/ 
Purpose 
Sample/Setting 
 
Major Variables 
Studied and 
Their Definitions 
 
Measurement/ 
Instrumentation 
 
Data 
Analysis 
Findings/ 
Results 
 
Level of evidence/ 
Decision for Use/Application to 
Practice 
Country: 
USA  
 
Funding: 
None 
  
Bias: author 
R.T.B. is on 
the 
CONSENTYX 
Advisory 
Board and has 
been the 
Principal 
Investigator of 
clinical trials 
performed for 
Golderma 
Laboratories, 
L.P. and 
Novartis 
AS role  and 
its 
relationship 
to stress and 
SD QOL 
-location in USA 
-current dx of skin 
ds with active 
symptoms over 
past 4 wks 
-no skin ds 
exclusions 
Exclusion:  
-non English 
speaking 
- Attrition: 
was 0.05 
two tailed 
SD. 
Gül & 
Çölgeçen, 
2015. 
Personality 
traits and 
common 
psychiatric 
conditions in 
adult patients 
with acne 
vulgaris 
Country: 
Turkey 
Psycho-social 
theory 
Design: 
prospective 
cohort study 
Purpose: 
investigate 
personality 
traits and 
common 
psych 
conditions in 
pts with adult 
AV 
N = 40 
Demographics: 
F = 34, M = 6, 25-
41 yrs of age 
Setting:  
Bozok University 
Medical School 
derm outpatient 
clinic 
Inclusion: 
-current dx of adult 
AV 
-25 yrs of age or 
IV: Adult pts with 
acne 
DV I: somatization 
DV II: depression 
DV III: anxiety 
 
 
 
 
Symptom 
checklist 90-
revised 
Eysenck 
personality 
questionnaire-
revised short 
form 
 
 
SPSS 
version 17 
Mann-
Whitney U 
test 
Spearman 
correlation 
analysis 
<0.05 is sig 
Dep p<0.001, 
anx p<0.001 
Strong 
positive 
correlation 
betw 
somatization, 
dep, anx and 
AV 
Level of Evidence: II 
Strength: control group, results 
consistent with previous studies, no 
pts given systematic txt for AV 
Weakness: self-reported by pts, 
small sample size  
Conclusion: common psych 
conditions occur with considerably 
high rates in adult pts with AV 
MBSR USE IN CHRONIC SKIN DISEASE 
# - number, aa – alopecia areata, ad – atopic dermatitis, AN – Asian,  anx – anxiety, AS – anxiety sensitivity, ASI-3 – Anxiety Sensitivity Index-3, asses – assessment, AV – acne vulgaris, B – Black, BDI – Beck Depression 
Inventory, betw – between, conco – concordance, dep – depression, derma(s) – dermatologist(s), derm – dermatology,  diff – different, DLQI – Dermatological quality of life scale, d/o – disorder, ds – disease, du – decubitus 
ulcer, dx – diagnosis, F – female, fsd – fungal skin disease, f/u – follow-up, HADS – Hospital Anxiety & Depression Scale, improv – improvement, info – information, instr – instruction, k – Kohen’s Kappa, lit – literature, M – 
male, MBSR – mindful-based stress reduction, mc – molluscum contagiosum,  med – medication, MTurk – Amazon’s Mechanical Turk through TurkPrime, neuro – neurological, NF – nonfatal, nmsc – non-melanoma skin 
cancer, NOS – Newcastle-Ottawa Scale, NR – non-randomized, outpt – outpatient, PICOS - Population, Interventions, Comparators, Outcomes, Study Design, PRISMA – preferred reported items for systematic reviews and meta-
analysis, psych – psychosis, psycho – psychological, pt(s) – patients(s),  QOL – quality of life, RCTs – randomized controlled studies – sig – significance, SD – skin disease, SI – suicidal ideation, sig – significant, ST – short 
term, tx – treatment, UK – United Kingdom, underes(d) – underestimate(d), USA – United States of America val – validated, vw – viral warts, W – White, yr(s) – year(s), wks - weeks 
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Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method/ 
Purpose 
Sample/Setting 
 
Major Variables 
Studied and 
Their Definitions 
 
Measurement/ 
Instrumentation 
 
Data 
Analysis 
Findings/ 
Results 
 
Level of evidence/ 
Decision for Use/Application to 
Practice 
Funding: none 
noted 
Bias: none 
noted 
older 
Exclusion –  
Neuro, psych, 
medical, alcohol, 
substance abuse co-
morbidities or med 
that may cause 
psych ds 
 
Hay et. al, 
2013. The 
Global Burden 
of Skin 
Disease in 
2010: An 
analysis of the 
prevalence & 
impact of skin 
conditions 
Country: UK, 
USA, 
Australia, 
Italy, Africa, 
Ethiopia, 
India, other 
global studies 
utilized 
Funding: 
Grant from 
Bill & Melinda 
Gates 
Foundation 
Bias: none 
stated 
Social 
cognitive 
theory 
Design: 
systematic lit 
review 
 
Purpose:  to 
determine top 
derm ds NF 
burden for 
187 countries 
N = 895 country-
years of data  
Demographics: 
M & F with 
eczema, psoriasis, 
AV, pruritus, aa, 
du, urticaria, 
scabies, fsd, 
impetigo, abscess, 
& other bacterial 
skin ds, cellulitis, 
vw, mc, & nmsc. 
Setting: Data from 
82 countries 
Inclusion: 
-1980-2010 with 
data on relevant ds 
Exclusion:  
-self-reported data 
unless val 
-occupational 
groups 
-non-random 
studies 
IV: skin ds 
DV: health burden 
 
Time frame of the 
intervention – 
1990-2010 
Baysian meta-
regression tool 
World databases 
ICD 10 
DisMod-MR Skin ds 
causes large 
and sig 
burden on 
derm pts in 
global 
context 
Level of Evidence: I 
Strength: severity of ds was 
considered, sig results 
Weakness: missing quality data at 
regional level, only focused on most 
prevalent skin ds, may have 
underestimated burden 
Conclusion: in 2010, SD was 18th 
leading cause of health burden 
worldwide 
MBSR USE IN CHRONIC SKIN DISEASE 
# - number, aa – alopecia areata, ad – atopic dermatitis, AN – Asian,  anx – anxiety, AS – anxiety sensitivity, ASI-3 – Anxiety Sensitivity Index-3, asses – assessment, AV – acne vulgaris, B – Black, BDI – Beck Depression 
Inventory, betw – between, conco – concordance, dep – depression, derma(s) – dermatologist(s), derm – dermatology,  diff – different, DLQI – Dermatological quality of life scale, d/o – disorder, ds – disease, du – decubitus 
ulcer, dx – diagnosis, F – female, fsd – fungal skin disease, f/u – follow-up, HADS – Hospital Anxiety & Depression Scale, improv – improvement, info – information, instr – instruction, k – Kohen’s Kappa, lit – literature, M – 
male, MBSR – mindful-based stress reduction, mc – molluscum contagiosum,  med – medication, MTurk – Amazon’s Mechanical Turk through TurkPrime, neuro – neurological, NF – nonfatal, nmsc – non-melanoma skin 
cancer, NOS – Newcastle-Ottawa Scale, NR – non-randomized, outpt – outpatient, PICOS - Population, Interventions, Comparators, Outcomes, Study Design, PRISMA – preferred reported items for systematic reviews and meta-
analysis, psych – psychosis, psycho – psychological, pt(s) – patients(s),  QOL – quality of life, RCTs – randomized controlled studies – sig – significance, SD – skin disease, SI – suicidal ideation, sig – significant, ST – short 
term, tx – treatment, UK – United Kingdom, underes(d) – underestimate(d), USA – United States of America val – validated, vw – viral warts, W – White, yr(s) – year(s), wks - weeks 
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Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method/ 
Purpose 
Sample/Setting 
 
Major Variables 
Studied and 
Their Definitions 
 
Measurement/ 
Instrumentation 
 
Data 
Analysis 
Findings/ 
Results 
 
Level of evidence/ 
Decision for Use/Application to 
Practice 
-sample size <100 
-experimental arm 
of clinical trial 
-estimates found 
and not data 
-studied specific 
groupings 
Montgomery 
et. al, 2016. 
The import-
ance of 
mindfulness in 
psych-osocial 
distress and 
quality of life 
in derm-
atology 
patients  
Country: UK 
Funding: 
Ecomonomic 
& social 
research 
council  
Bias: none 
reported 
Quality of life 
theory  
Design: 
cross-
sectional 
Purpose: 
Examine 
relationship 
betw 
mindfulness 
& distress in 
derm pts 
N = 120 
Demographics: 
M = 35, F = 84, not 
reported = 1, W = 
104, AN = 5, B = 
1, other = 8, not 
reported = 2 
Incl: 
-pt at one hospital 
-literate 
-dx acne 
Exc  
-primary pscy dx 
affecting skin 
-skin cancer 
IV: Mindfulness 
DV I: anx 
DV II: dep 
Five Facet 
Mindfulness 
Questionnaire 
Five point scale 
SD subjective 
severity  
Skin Shame 
ScaleBrief Fear 
of Negative 
Evaluation 
HADS 
DLQI 
Hierarchical 
regression 
analyses 
 
Clinically sig 
positive 
correlation 
levels of anx 
(p<0.05). 
 
Level of Evidence: III 
Strength: outcomes congruent with 
previous studies, sig correlation 
between mindfulness and pscyho 
distress 
Weakness: cross-sectional 
precludes strong conclusions, 
objective severity of SD used, 
sample predominantly W F, samples 
only from one derm clinic. 
Conclusion: higher levels of 
mindfulness are associated with 
reduced psycho distress and 
improved derm QOL 
Niazi & Niazi, 
2011. 
Mindfulness-
based stress 
reduction: A 
non-pharm-
acological 
Mindfulness 
Theory 
Design: 
systematic 
review  
Purpose:  
determine 
efficacy of 
MBSR in tx 
N = 18 
Demographics: 
-both genders 
Setting: multiple 
Inclusion: 
 RCTs 
-English-language 
IV: MBSR 
 
DV: chronic ds 
 
Time frame of the 
intervention – 
anytime 
-anx, dep, stress, 
QOL 
-recurrence & 
relapse of ds 
Researchers 
abstracted 
info 
themselves 
for each 
article 
All studies 
showed 
improv in ds 
condition 
after MBSR 
Level of Evidence: I 
Strength: Pubmed and Cochrane 
searched, initial results 2,607 
articles, 32 found relevant after first 
screen, and 18 of these 32 were full 
text. 
Weakness: no data analysis 
MBSR USE IN CHRONIC SKIN DISEASE 
# - number, aa – alopecia areata, ad – atopic dermatitis, AN – Asian,  anx – anxiety, AS – anxiety sensitivity, ASI-3 – Anxiety Sensitivity Index-3, asses – assessment, AV – acne vulgaris, B – Black, BDI – Beck Depression 
Inventory, betw – between, conco – concordance, dep – depression, derma(s) – dermatologist(s), derm – dermatology,  diff – different, DLQI – Dermatological quality of life scale, d/o – disorder, ds – disease, du – decubitus 
ulcer, dx – diagnosis, F – female, fsd – fungal skin disease, f/u – follow-up, HADS – Hospital Anxiety & Depression Scale, improv – improvement, info – information, instr – instruction, k – Kohen’s Kappa, lit – literature, M – 
male, MBSR – mindful-based stress reduction, mc – molluscum contagiosum,  med – medication, MTurk – Amazon’s Mechanical Turk through TurkPrime, neuro – neurological, NF – nonfatal, nmsc – non-melanoma skin 
cancer, NOS – Newcastle-Ottawa Scale, NR – non-randomized, outpt – outpatient, PICOS - Population, Interventions, Comparators, Outcomes, Study Design, PRISMA – preferred reported items for systematic reviews and meta-
analysis, psych – psychosis, psycho – psychological, pt(s) – patients(s),  QOL – quality of life, RCTs – randomized controlled studies – sig – significance, SD – skin disease, SI – suicidal ideation, sig – significant, ST – short 
term, tx – treatment, UK – United Kingdom, underes(d) – underestimate(d), USA – United States of America val – validated, vw – viral warts, W – White, yr(s) – year(s), wks - weeks 
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Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method/ 
Purpose 
Sample/Setting 
 
Major Variables 
Studied and 
Their Definitions 
 
Measurement/ 
Instrumentation 
 
Data 
Analysis 
Findings/ 
Results 
 
Level of evidence/ 
Decision for Use/Application to 
Practice 
approach for 
chronic 
illnesses  
Country: 
Pakistan 
 
Funding: 
None 
  
Bias: none 
noted 
of chronic ds -humans 
Exclusion:  
-animal studies 
-not full text 
articles 
-funded research 
 
performed, only researcher summary 
of results  
Conclusion: MBSR may help a 
broad range of pts cope with their 
clinical and non-clinical problems 
Patel et. al, 
2019.  
Association 
between atopic 
dermatitis, 
depression, 
and suicidal 
ideation: 
A systematic 
review and 
meta-analysis 
Country: 
USA 
Funding: 
None 
Bias: none 
noted 
Cognitive 
Theory 
Design: 
systematic 
review 
 
Purpose:   
Determine 
the complex 
relationship 
between AD 
and dep 
N = 106 
Demographics: 
Setting:  
-M & F 
Inclusion: 
 -cross-sectional or 
cohort study 
-assessed: AD 
and/or suicide 
-at least 20 subjects 
with AD 
-any language 
Exclusion: 
-reviews 
-editorials 
-duplicated studies 
IV: AD 
 
DV 1: suicide 
DV 2: dep 
 
Time frame of the 
intervention –  
1963-2018 
 
 
 
 
 
 
 
 
 
 
 
 
NOS 
 
OpenMeta 1 in 6 
persons with 
AD had 
clinical dep, 
1 in 4 dep 
symptoms, 1 
in 8 SI. 
Level of Evidence: I 
Strength: clinically significant and 
relevant 
Weakness: AD measured with diff 
dep scales, self-reported dep 
Conclusion: pts with AD have a 
higher risk of dep and SI 
MBSR USE IN CHRONIC SKIN DISEASE 
# - number, aa – alopecia areata, ad – atopic dermatitis, AN – Asian,  anx – anxiety, AS – anxiety sensitivity, ASI-3 – Anxiety Sensitivity Index-3, asses – assessment, AV – acne vulgaris, B – Black, BDI – Beck Depression 
Inventory, betw – between, conco – concordance, dep – depression, derma(s) – dermatologist(s), derm – dermatology,  diff – different, DLQI – Dermatological quality of life scale, d/o – disorder, ds – disease, du – decubitus 
ulcer, dx – diagnosis, F – female, fsd – fungal skin disease, f/u – follow-up, HADS – Hospital Anxiety & Depression Scale, improv – improvement, info – information, instr – instruction, k – Kohen’s Kappa, lit – literature, M – 
male, MBSR – mindful-based stress reduction, mc – molluscum contagiosum,  med – medication, MTurk – Amazon’s Mechanical Turk through TurkPrime, neuro – neurological, NF – nonfatal, nmsc – non-melanoma skin 
cancer, NOS – Newcastle-Ottawa Scale, NR – non-randomized, outpt – outpatient, PICOS - Population, Interventions, Comparators, Outcomes, Study Design, PRISMA – preferred reported items for systematic reviews and meta-
analysis, psych – psychosis, psycho – psychological, pt(s) – patients(s),  QOL – quality of life, RCTs – randomized controlled studies – sig – significance, SD – skin disease, SI – suicidal ideation, sig – significant, ST – short 
term, tx – treatment, UK – United Kingdom, underes(d) – underestimate(d), USA – United States of America val – validated, vw – viral warts, W – White, yr(s) – year(s), wks - weeks 
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Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method/ 
Purpose 
Sample/Setting 
 
Major Variables 
Studied and 
Their Definitions 
 
Measurement/ 
Instrumentation 
 
Data 
Analysis 
Findings/ 
Results 
 
Level of evidence/ 
Decision for Use/Application to 
Practice 
Pietrzak et. al, 
2017. 
Depressive-
ness, measured 
with Beck 
Depression 
Inventory, in 
patients with 
psoriasis. 
Country: 
Poland 
Funding:Med-
ical University 
of Lublin 
Funds 
Bias: selection 
bias 
Pyschodynami
c theory 
Design: 
cross-
sectional non 
prospective 
Purpose: 
identify 
demographic 
and clinical 
factors 
predisposing 
dep during 
course of 
psoriasis 
N = 239 
Demographics:  
-pts with psoriasis: 
ages 15-76 yrs 
-31.8% F 
-health controls: 
123 pts ages 17-74 
yrs, F = 32.5% 
 
Setting: a derm 
medical center in 
Poland 
Inclusion: 
-current dx of 
psoriasis 
 Exclusion: 
-hx of recent 
myocardial ds 
-mental disorders 
-immuno-
suppressive usage 
-no anti-depression 
meds 
 
IV: psoriasis  
DV: dep 
 
Time Frame: 2014-
2016 
BDI 
Shapiro-
Wilk test 
Mann-
Whitney U-
test 
Kruskal-
Wallis test 
Pearson’s 
chi-square 
Fisher’s 
exact test 
Spearman 
rank 
correlation 
coefficients 
Multivariate 
analysis = 
independent 
predictors of 
any grade of 
dep 
correlated sig 
with presence 
of psoriasis 
 
Level of Evidence: III 
Strength: no pts on anti-depression 
meds, results similar to majority of 
past research 
Weakness: cross-sectional, 
selection bias, control group were 
other derm pts 
Conclusion: pts with psoriasis 
regardless of severity are at 
increased risk of dep 
Salman et. al, 
2016. Social 
anxiety and 
quality of life 
in vitiligo and 
acne patients 
with facial 
involvement  
Country: 
Turkey 
Interpersonal 
Theory  
Design: 
cross-
sectional 
controlled 
 
Purpose: 
compare 
levels of 
depression, 
anxiety, and 
N = 74 acne study 
participants 
Demographics: 
M = 34, F = 40, 
over 18 yrs. 37 
vitiligo, 37 acne, & 
74 age/sex matched 
health controls over 
18 yrs  
Setting: outpt derm 
IV: acne  
 
DV1: 
anxiety/QOL/depres
sion 
 
Time frame of the 
intervention –avg 
interview 40 min 
Subjective: 
Visual analog 
scale of 10 cm 
Objective: EATG 
 
LSAS (Sn 
73.66% and Sp 
76.70%) 
HADS (Sp of 
79& and Sn of 
SPSS 
Kolmogorov
-Smirnov 
test 
Chi square 
test 
Student’s t-
test 
Pearson’s 
correlation 
Social 
anxiety, 
depression 
and anxiety 
levels of acne 
patients were 
significantly 
higher than 
health 
controls 6.4 
Level of Evidence: III 
Strength: all aspects of social 
anxiety addressed, results congruent 
with previous studies,  
Weakness: cross-sectional design, 
relatively small sample size 
Conclusion: facial acne was shown 
to cause increased levels of social 
anxiety, depression, and impaired 
QOL. It is important to have 
MBSR USE IN CHRONIC SKIN DISEASE 
# - number, aa – alopecia areata, ad – atopic dermatitis, AN – Asian,  anx – anxiety, AS – anxiety sensitivity, ASI-3 – Anxiety Sensitivity Index-3, asses – assessment, AV – acne vulgaris, B – Black, BDI – Beck Depression 
Inventory, betw – between, conco – concordance, dep – depression, derma(s) – dermatologist(s), derm – dermatology,  diff – different, DLQI – Dermatological quality of life scale, d/o – disorder, ds – disease, du – decubitus 
ulcer, dx – diagnosis, F – female, fsd – fungal skin disease, f/u – follow-up, HADS – Hospital Anxiety & Depression Scale, improv – improvement, info – information, instr – instruction, k – Kohen’s Kappa, lit – literature, M – 
male, MBSR – mindful-based stress reduction, mc – molluscum contagiosum,  med – medication, MTurk – Amazon’s Mechanical Turk through TurkPrime, neuro – neurological, NF – nonfatal, nmsc – non-melanoma skin 
cancer, NOS – Newcastle-Ottawa Scale, NR – non-randomized, outpt – outpatient, PICOS - Population, Interventions, Comparators, Outcomes, Study Design, PRISMA – preferred reported items for systematic reviews and meta-
analysis, psych – psychosis, psycho – psychological, pt(s) – patients(s),  QOL – quality of life, RCTs – randomized controlled studies – sig – significance, SD – skin disease, SI – suicidal ideation, sig – significant, ST – short 
term, tx – treatment, UK – United Kingdom, underes(d) – underestimate(d), USA – United States of America val – validated, vw – viral warts, W – White, yr(s) – year(s), wks - weeks 
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Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method/ 
Purpose 
Sample/Setting 
 
Major Variables 
Studied and 
Their Definitions 
 
Measurement/ 
Instrumentation 
 
Data 
Analysis 
Findings/ 
Results 
 
Level of evidence/ 
Decision for Use/Application to 
Practice 
 
Funding: 
None 
  
Bias: none 
noted 
QOL in acne 
pts vs non-
acne pts 
clinic 
Inclusion: 
 -over 18 yrs 
-dx vitiligo or acne 
(lesions visible at 
least 1m) 
Exclusion:  
-another other 
facial condition, 
not mentally able to 
use questionnaire 
Attrition: 0% 
83%) 
DLQI (Sp = 81% 
and Sn = 83%). 
+/1 6.2 
(p<0.05). 
QOL was 
negatively 
correlated 
with social 
anxiety and 
depression 
psychological assessment for each 
acne pt. 
Victorson et. 
al, 2015 
Country: 
USA 
Funding: 
None 
Bias: none 
noted  
PICOS 
Framework 
Design: 
systematic 
review and 
meta-analysis 
 
Purpose:   
Determine 
benefits of 
MBSR on 
various 
populations 
and 
conditions 
N = 59 
Demographics: 
M = 25% 
F = 75% 
Setting: various  
Inclusion: 
 -MBSR program 2 
wks or longer 
-RCTs 
Exclusion: 
-f/u, observational, 
and NR studies 
-intensive programs 
-inpatient 
IV: MBSR 
 
DV1: various 
population 
conditions 
 
Time frame of the 
intervention – 2002 
- 2012 
 
 
 
 
 
 
 
 
PRISMA 
Cochran 
Collection 
Hedge’s g 
Cochrane 
risk of bias 
tool 
SPSS 
version 22 
Partial 
evidence for 
MBSR to 
provide ST 
benefits 
across wide 
range of 
medicine-
relevant 
populations 
-MBSR is 
superior to no 
txt at all 
Level of Evidence: I 
Strength: large # of studies, 
significant evidence for ST benefit 
of MBSR in managing symptom 
burden and affecting modifiable 
health behaviors 
Weakness: publication bias was not 
examined across included studies, 
many studies failed to report risk 
bias and/or blinding, for several 
analytic comparisons, the 
homogeneity of variance assumption 
was not met 
Conclusion: partial evidence for ST 
effectiveness of MBSR on various 
lifestyle medicine-relevant contexts 
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AM – America, Anx – anxiety, ASI-3 – Anxiety Sensitivity Index-3, AV – acne vulgaris, BDI – Beck Depression Inventory, BFNE – brief fear of negative evaluation, BMRT – 
Baysian meta-regression tool, CS – cross sectional, CST – cross sectional controlled, DASS-21 – Depression Anxiety and Stress Sclases-21, Dep – depression, DLQI – 
dermatological quality of life scale, ds – disease, EPQ – Eysenck Personality Questionnaire, F – females, FFMQ – five facet mindfulness questionnaire, FO – foreign country, 
GSSS – Global self-reported severity of skin disease, HADS – hospital anxiety and depression scale, HGF – high glycemic food, hr – hour, LSAS – Liebowitz social anxiety 
scale, M – male,  MBSR – mindful-based stress reduction, Mn – mean, N – number of total participants or studies, Pt – patient, QOL – quality of life, SC 90-R – Symptoms 
checklist 90-revised, SD – skin disease, SR – systematic review, SS – subjective severity, SSS – skin shame scale, WD – world database, – increases, – decreases 
 
Appendix F 
Synthesis Table 
 
     Author      
 Dalgard Dixon Gul Hay Montgomery Niazi Patel Pietrzak Salman Victorson 
Year 2018 2018 2015 2013 2016 2011 2019 2017 2016 2015 
Design/Level of 
Evidence: 
CS/II CS/III CS/II SR/I CS/III SR/I SR/I CS/III CS/III SR/I 
     Study 
Characteristics 
     
Demographics           
Age (yrs) 18 yrs and > 
 
18 yrs and > 
 
25 yrs and > All ages 18 yrs and > 
 
All ages All ages 15-76 yrs 18 yrs and > 
 
All ages 
 Male/Female  Both genders 73/161 6/34 Both genders 35/84 Both genders Both genders 163/76 34/40 Both genders 
(25%/75%) 
Setting:           
AM  X     X   X 
FO X  X X X X  X X  
Sample Size           
 3,635 237 40 895 119 18 106 239 74 59 
Measurement 
Tools Used 
          
ASI-3  X         
BDI        X   
BFNE     X      
BMRT    X       
DASS-21  X         
DLQI         X  
EPQ   X        
FFMQ     X      
GSSS  X         
HADS X    X    X  
LSAS         X  
Previous Study 
Results 
     X X   X 
SC 90-R   X        
Skindex-16  X         
SS     X      
SSS     X      
WD    X       
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AM – America, Anx – anxiety, ASI-3 – Anxiety Sensitivity Index-3, AV – acne vulgaris, BDI – Beck Depression Inventory, BFNE – brief fear of negative evaluation, BMRT – 
Baysian meta-regression tool, CS – cross sectional, CST – cross sectional controlled, DASS-21 – Depression Anxiety and Stress Sclases-21, Dep – depression, DLQI – 
dermatological quality of life scale, ds – disease, EPQ – Eysenck Personality Questionnaire, F – females, FFMQ – five facet mindfulness questionnaire, FO – foreign country, 
GSSS – Global self-reported severity of skin disease, HADS – hospital anxiety and depression scale, HGF – high glycemic food, hr – hour, LSAS – Liebowitz social anxiety 
scale, M – male,  MBSR – mindful-based stress reduction, Mn – mean, N – number of total participants or studies, Pt – patient, QOL – quality of life, SC 90-R – Symptoms 
checklist 90-revised, SD – skin disease, SR – systematic review, SS – subjective severity, SSS – skin shame scale, WD – world database, – increases, – decreases 
 
Interventions           
Examination of 
stress and its 
relationship to SD, 
anx, & dep 
 X         
Dermatologists 
assessed pt dep 
X          
Surveys   X  X   X X  
Review of literature    X  X X   X 
MBSR      X     
Major Findings           
Evaluatd Dep Level           
Anxiety            
Suicidal Ideation 
shown to increase 
with SD 
  X    X    
Adherence to 
Treatment 
          
Anx shown to 
increase with SD 
  X  X      
Burden of SD            
Mindfulness effect 
on dep 
          
Mindfulness effect 
on anx 
          
Dep shown to 
increase with SD 
  X  X  X X   
Stress is related to 
increased dep & anx 
 X         
Benefit from MBSR 
on various clinical 
and non-clinical 
symptoms in 
multiple people 
with and without ds 
         X 
QOL           
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Appendix G 
 
The ACE Start Model of Knowledge Transformation  
 
 
 
 
 
 
 
 
 
ACE Star Model of Knowledge [Online image]. (2012).  
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Appendix H 
Self-Efficacy Model 
                             
 
 
 
Self-Efficacy Model [Online image]. (2010). 
 
 
 
COMPREHENSIVE ACNE TREATMENT 
52 
 
 
Appendix I 
Estimated Budget Plan 
Proposed Expenses 
Figure I.1 
 
 Expenses In-Kind Support 
Personnel   
Project Director (Kylee 
Huesbch, RN) 
$40/hr for 20 hours/ week x 
12 weeks 
$2120 (21%) $7680 (79%) 
Consultant, Dr. Thrall, DNP, 
RN, FNP-BC,  
$60/hr for 15 hours/wk x 12 
weeks 
(0%) $10800 
Kylee Huebsch, RN, Office 
Assistant, gather and prep 
data for analytics 
$14/hr for 2 hours/wk x 12 
weeks 
(0%) $336 
Tirsa Quartullo, DNP, @ 
$75/hr 
4 hours/week for 12 weeks 
 $3,600.00 
Lee-Anne Berumen, Office 
Manager, 1 hour/week @ 
$30/hr for 15 weeks 
 $450.00 
Office staff/MA for pamphlet 
education and patient 
recruitment. $14/hr x 4hrs for 
4 weeks. 
 $224.00 
Meeting Room & 
Equipment 
  
Meeting Room 
(3) 90-minutes meetings at 
$75/hr 
$225  
Refreshments for Meetings 
Up to 4 people at $12pp 
$144  
Research & meetings 
printouts, misc office supplies 
$70  
Cell phone to call patients for 
12 weeks 
$400.00  
Travel Reimbursement for 
Personnel 
  
50 miles roundtrip x 8 
recruitment of participants, x 
$540  
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3meetings @ .45/mile 
Tuition, books, fees   
ASU May 2017 – May 2019 
(estimated along with 1 year 
leave of absence.) 
$78,000 $9500 
TOTAL:  $81,499 $32,590 
 
Project Timeline Showing Quarterly Benchmarks 
Figure I.2 
 
Activity Responsibility 1st Quarter Fall 
2017 
2nd Quarter 
Summer 2018 
3rd Quarter Fall 
2019 
Project 
Development & 
IRB Approval 
Project Director X   
Exhaustive 
Evidence-Based 
Literature 
Review 
Project Director X   
Baseline Data 
Collection and 
Analysis 
Project Director/ 
APN/Office Staff 
 X  
Present Initial 
Data Analysis & 
Project 
Foundation to 
Key 
Stakeholders 
Project 
Director/APN 
 X  
Project 
Implementation 
Guideline 
Development 
Project 
Director/APN 
  X 
Project 
Evaluation, Data 
Analysis, 
Sustainability 
Plan 
   X 
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Budget Plan: Projected Cost 
 
Figure I.3 
 
Projected cost 
Expense Item Expenses In-Kind Support 
 
Personnel 
    
    Project director (DNP student)       
    $40/hr for ~20 hrs per week x 
    12 weeks 
$1,920 (20%) $7,680 (80%) 
    Advanced practice provider @ 
    $45/hr for 15hrs/week x12 weeks 
 
     Dermatologist DNP @ $75/hr 
     4 hours/week for 12 weeks  
 
     Office manager 1 hour/week @ $30/hr 
for          15 weeks 
 
    Office staff/MA for pamphlet education 
and patient recruitment. $14/hr x 4hrs for 4 
weeks. 
                      
 
Equipment/Materials 
     
    Paper educational pamphlets $5/pt x 20 
pts   
                                
                        
                            
 $4,104 (38%) 
  
  
$3,600 
  
 
$450.00 
  
 
 
 
 
 
 
 
$100 
$6,696 (62%)  
 
  
  
 
 
 
 
 
$224 
 
 
 
 
 
Office/Operations 
    Utilizing dermatology clinic for 
navigation      sessions and  recruitment for 
16 hours per 
    week for 12 weeks (office space, 
    electricity, air conditioning) 
     
    Utilizing wellness center for outcome  
    data collection and statistical analysis  
    (office space, electricity, air 
conditioning) 
 
 
$10 Incentives for participants who 
complete the intervention  
 
 
 
Total Expenses  
 
  
  
  
  
  
  
  
  
 
 
$200 
 
 
 
 
$10,374 
  
 
$600.00 
 
  
 
 
$400.00 
  
  
 
 
 
 
 
 
$15,600 
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Timeline with Quarterly Benchmarks: Project Timeline 
 
Figure I.4 
 
 
 
